SCHEMBL264306

SCHEMBL264306

BrC1CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14476043 1.00
SCHEMBL5785673 1.00
SCHEMBL2356897 0.81
SCHEMBL622798 0.79
SCHEMBL29990855 0.75
SCHEMBL29990916 0.75
SCHEMBL8977052 0.71
SCHEMBL28108443 0.71
SCHEMBL3599832 0.69
SCHEMBL28875831 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 351 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119650861-A Sodium ion battery electrolyte and preparation method and application thereof 中国科学院大连化学物理研究所 2025-03-18 CN claimed
CN-117936909-A Quick-charging low-temperature electrolyte and preparation method and application thereof 中国科学院大连化学物理研究所 2024-04-26 CN claimed
CN-113121472-B Method for preparing N-sulfonyl pyrrolidine compound by using gold complex 上海应用技术大学 2022-12-16 CN claimed
CN-113381074-A Low-temperature electrolyte and application thereof 厦门大学 2021-09-10 CN claimed
CN-113121472-A Method for preparing N-sulfonyl pyrrolidine compound by using gold complex 上海应用技术大学 2021-07-16 CN claimed
US-12637450-B2 Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways GLOBAL CANCER TECHNOLOGY INC. (US) 2026-05-26 US disclosed
US-20260116881-A1 KIF MODULATOR COMPOUNDS AND METHODS OF USE IAMBIC THERAPEUTICS INC (US) 2026-04-30 US disclosed
EP-4076459-B1 PRMT5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2026-04-29 EP disclosed
US-12595248-B2 PRMT5 inhibitors MERCK SHARP & DOHME LLC (US) 2026-04-07 US disclosed
US-12478621-B2 Substituted aminoquinolones as dgkalpha inhibitors for immune activation DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2025-11-25 US disclosed
US-20250333414-A1 HETARYL SUBSTITUTED INDAZOLES AND BENZIMIDAZOLES AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2025-10-30 US disclosed
US-20250221966-A1 RXFP1 AGONISTS BRISTOL MYERS SQUIBB CO (US) 2025-07-10 US disclosed
US-5294705-A Process for the preparation of a 3-substituted thio-3-cephem compound MEIJI SEIKA KAISHA, LTD. (JP) 1994-03-15 US disclosed
CN-1072686-A Has Pyrmidine nucleoside derivatives of anti-tumor activity and its production and use SANKYO CO (JP) 1993-06-02 CN disclosed
EP-0504404-A1 PROCESS FOR PRODUCING 3-SUBSTITUTED THIO-3-CEPHEM COMPOUND MEIJI SEIKA KAISHA LTD. (JP) 1992-09-23 EP disclosed
CN-1052309-A Cephalosporins derivatives and preparation thereof and application MEIJI SEIKA KAISHA (JP) 1991-06-19 CN disclosed
EP-0432042-A2 Cephalosporin derivatives and their production and uses MEIJI SEIKA KAISHA LTD. (JP) 1991-06-12 EP disclosed
US-4569925-A OXIDATION CATALYST FOR HYDROCARBONS EXXON RESEARCH & ENGINEERING CO. (US) 1986-02-11 US disclosed
US-4381975-A Aluminium electroplating solution U.S. PHILIPS CORPORATION (US) 1983-05-03 US disclosed
US-4043943-A Process for producing a mixed oxide of vanadium and phosphorus having an improved intrinsic surface area CHEVRON RESEARCH COMPANY (US) 1977-08-23 US disclosed